Last reviewed · How we verify

Alpha-Lipoic Acid(α-LA) — Competitive Intelligence Brief

Alpha-Lipoic Acid(α-LA) (Alpha-Lipoic Acid(α-LA)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antioxidant/Mitochondrial cofactor. Area: Metabolic/Endocrine.

marketed Antioxidant/Mitochondrial cofactor Metabolic/Endocrine Small molecule Live · refreshed every 30 min

Target snapshot

Alpha-Lipoic Acid(α-LA) (Alpha-Lipoic Acid(α-LA)) — Shanghai Zhongshan Hospital. Alpha-lipoic acid acts as a mitochondrial cofactor and antioxidant that reduces oxidative stress and improves cellular energy metabolism.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Alpha-Lipoic Acid(α-LA) TARGET Alpha-Lipoic Acid(α-LA) Shanghai Zhongshan Hospital marketed Antioxidant/Mitochondrial cofactor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antioxidant/Mitochondrial cofactor class)

  1. Shanghai Zhongshan Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Alpha-Lipoic Acid(α-LA) — Competitive Intelligence Brief. https://druglandscape.com/ci/alpha-lipoic-acid-la. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing